Gene Review:
KIR3DL1 - killer cell immunoglobulin-like receptor,...
Homo sapiens
Synonyms:
AMB11, CD158 antigen-like family member E, CD158E, CD158E1, CD158e1/2, ...
Cook,
Milligan,
Fegan,
Darbyshire,
Mahendra,
Craddock,
Moss,
Briggs,
Kröger,
Binder,
Zabelina,
Wolschke,
Schieder,
Renges,
Ayuk,
Dahlke,
Eiermann,
Zander,
Stewart,
Laugier-Anfossi,
Vély,
Saulquin,
Riedmuller,
Tisserant,
Gauthier,
Romagné,
Ferracci,
Arosa,
Moretta,
Sun,
Ugolini,
Vivier,
Leung,
Iyengar,
Triplett,
Turner,
Behm,
Holladay,
Houston,
Handgretinger,
Vyas,
Selvakumar,
Steffens,
Dupont,
Chen,
Huang,
Poggi,
Contini,
Catellani,
Setti,
Murdaca,
Zocchi,
- Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker, A.B., Phillips, J.H., Figdor, C.G., Lanier, L.L. J. Immunol. (1998)
- Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. López-Vázquez, A., Miña-Blanco, A., Martínez-Borra, J., Njobvu, P.D., Suárez-Alvarez, B., Blanco-Gelaz, M.A., González, S., Rodrigo, L., López-Larrea, C. Hum. Immunol. (2005)
- Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. Winter, C.C., Gumperz, J.E., Parham, P., Long, E.O., Wagtmann, N. J. Immunol. (1998)
- Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus. Santin, I., de Nanclares, G.P., Calvo, B., Gaafar, A., Castaño, L., Bilbao, J.R. Hum. Immunol. (2006)
- A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia. Arnheim, L., Dillner, J., Sanjeevi, C.B. Tissue Antigens (2005)
- Chromosome 21 KIR channels in brain development. Thiery, E., Thomas, S., Vacher, S., Delezoide, A.L., Delabar, J.M., Créau, N. J. Neural Transm. Suppl. (2003)
- KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Vilches, C., Parham, P. Annu. Rev. Immunol. (2002)
- Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Martin, M.P., Gao, X., Lee, J.H., Nelson, G.W., Detels, R., Goedert, J.J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., Wilson, M., O'Brien, S.J., Carrington, M. Nat. Genet. (2002)
- Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Boyington, J.C., Motyka, S.A., Schuck, P., Brooks, A.G., Sun, P.D. Nature (2000)
- The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Cook, M.A., Milligan, D.W., Fegan, C.D., Darbyshire, P.J., Mahendra, P., Craddock, C.F., Moss, P.A., Briggs, D.C. Blood (2004)
- Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Stewart-Jones, G.B., di Gleria, K., Kollnberger, S., McMichael, A.J., Jones, E.Y., Bowness, P. Eur. J. Immunol. (2005)
- Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Hani, E.H., Boutin, P., Durand, E., Inoue, H., Permutt, M.A., Velho, G., Froguel, P. Diabetologia (1998)
- Simultaneous control of third-degree graft-versus-host disease and prevention of recurrence of juvenile myelomonocytic leukemia (JMML) with 6-mercaptopurine following fulminant JMML relapse early after KIR-mismatched bone marrow transplantation. Stachel, D.K., Leipold, A., Kuhlen, M., Gravou-Apostolatou, C., Hirv, K., Bader, P., Niemeyer, C.M., Beck, J.D., Holter, W. J. Pediatr. Hematol. Oncol. (2005)
- Establishment and characterization of two human bladder cancer cell lines. Naito, S., Kotoh, S., Koga, H., Hasegawa, S., Yamasaki, T., Noma, H., Kumazawa, J. Hum. Cell (1996)
- The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. Khakoo, S.I., Geller, R., Shin, S., Jenkins, J.A., Parham, P. J. Exp. Med. (2002)
- Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. Gardiner, C.M., Guethlein, L.A., Shilling, H.G., Pando, M., Carr, W.H., Rajalingam, R., Vilches, C., Parham, P. J. Immunol. (2001)
- Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. Stewart, C.A., Van Bergen, J., Trowsdale, J. J. Immunol. (2003)
- Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. Chwae, Y.J., Chang, M.J., Park, S.M., Yoon, H., Park, H.J., Kim, S.J., Kim, J. J. Immunol. (2002)
- The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. Pando, M.J., Gardiner, C.M., Gleimer, M., McQueen, K.L., Parham, P. J. Immunol. (2003)
- Functional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells. O'connor, G.M., Guinan, K.J., Cunningham, R.T., Middleton, D., Parham, P., Gardiner, C.M. J. Immunol. (2007)
- Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Lopez-Larrea, C., Blanco-Gelaz, M.A., Torre-Alonso, J.C., Bruges Armas, J., Suarez-Alvarez, B., Pruneda, L., Couto, A.R., Gonzalez, S., Lopez-Vázquez, A., Martinez-Borra, J. Arthritis Res. Ther. (2006)
- NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. Litwin, V., Gumperz, J., Parham, P., Phillips, J.H., Lanier, L.L. J. Exp. Med. (1994)
- DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. Chan, H.W., Kurago, Z.B., Stewart, C.A., Wilson, M.J., Martin, M.P., Mace, B.E., Carrington, M., Trowsdale, J., Lutz, C.T. J. Exp. Med. (2003)
- Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor. Cambiaggi, A., Verthuy, C., Naquet, P., Romagné, F., Ferrier, P., Biassoni, R., Moretta, A., Moretta, L., Vivier, E. Proc. Natl. Acad. Sci. U.S.A. (1997)
- Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site. Richardson, J., Reyburn, H.T., Luque, I., Valés-Gómez, M., Strominger, J.L. Eur. J. Immunol. (2000)
- Killer cell inhibitory receptors involved in graft-versus-host disease and graft-versus-leukemia effect in allogeneic hematopoietic stem cell transplantation - review. Chen, C., Huang, S.L. Zhongguo Shi Yan Xue Ye Xue Za Zhi (2004)
- Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual. Vyas, Y., Selvakumar, A., Steffens, U., Dupont, B. Tissue Antigens (1998)
- Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Stewart, C.A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F.A., Moretta, A., Sun, P.D., Ugolini, S., Vivier, E. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors. Poggi, A., Contini, P., Catellani, S., Setti, M., Murdaca, G., Zocchi, M.R. Eur. J. Immunol. (2005)
- Altered natural killer cells in type 1 diabetic patients. Rodacki, M., Svoren, B., Butty, V., Besse, W., Laffel, L., Benoist, C., Mathis, D. Diabetes (2007)
- Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells. Valiante, N.M., Phillips, J.H., Lanier, L.L., Parham, P. J. Exp. Med. (1996)
- A human killer inhibitory receptor specific for HLA-A1,2. Döhring, C., Scheidegger, D., Samaridis, J., Cella, M., Colonna, M. J. Immunol. (1996)
- Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. Leung, W., Iyengar, R., Triplett, B., Turner, V., Behm, F.G., Holladay, M.S., Houston, J., Handgretinger, R. J. Immunol. (2005)
- KIR haplotype content at the allele level in 77 Northern Irish families. Middleton, D., Meenagh, A., Gourraud, P.A. Immunogenetics (2007)
- Low Number of Donor Activating Killer Immunoglobulin-Like Receptors (KIR) Genes but not KIR-Ligand Mismatch Prevents Relapse and Improves Disease-Free Survival in Leukemia Patients After In Vivo T-Cell Depleted Unrelated Stem Cell Transplantation. Kr??ger, N., Binder, T., Zabelina, T., Wolschke, C., Schieder, H., Renges, H., Ayuk, F., Dahlke, J., Eiermann, T., Zander, A. Transplantation (2006)